Geevarghese, Geejo

Geevarghese, Geejo was paid $162K by Medicaid between Jan 2018 and Mar 2024, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.

33Billing provider infoGEEVARGHESE, GEEJO
MIDDLETOWN, NY 10941

33aNPI1417187345assigned 07/27/2009

33bProvider typeFamily Medicine Physician

28Total paid$162K

24GClaims1,572

24DCodes billed7

24AFirst – last monthJan 2018 – Mar 2024

Compared with peers

Next to other Family Medicine Physician providers in New York

Rank by total paid#456 of 2,605

Median peer was paid$10K

This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	79	$3K
2019	118	$13K
2020	299	$32K
2021	386	$42K
2022	577	$60K
2023	94	$11K
2024incomplete	19	$804.43

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	35%	661	657	$57K
S9083	Global fee urgent care centers	26%	281	279	$42K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	22%	263	263	$35K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	316	315	$24K
87631		1.0%	15	14	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	18	18	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	18	18	$450.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.